Yahoo Web Search

    • ERYTECH: Trials In Pancreatic Cancer (NASDAQ:ERYP)

      Seeking Alpha· 1 day ago

      ERYTECH Pharma S.A (ERYP) has its lead drug candidate Eryaspase (Trybeca-1) in a phase 3 trial in 2nd line pancreatic cancer with data expected in the first quarter of 2021. The idea was that ...

    • Tackling Dangerous Drug Shortages

      US News Health· 2 days ago

      When Steve Lagoudis was diagnosed with bladder cancer two years ago, his doctor gave him a powerful immunotherapy that was the standard of care: bacillus...